$KURA

1 thesis
bullish 100%neutral 0%bearish 0%
Avg return (3m)
Win rate (3m)
(0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

$KURASEC Form 4bullish
Long 100,000 shares of KURA
Bought 100,000 @ $11.12 avg · $1,112,000 · 2026-08-17

Form 4: WILSON TROY EDWARD bought KURA

WILSON TROY EDWARD (President and CEO at Kura Oncology, Inc.) reported an open-market purchase of 100,000 shares of KURA at an average $11.12, roughly $1,112,000, in a Form 4 filed 2026-08-17.

View filing on SEC.gov →

End of results.